MR enteroclysis using iron oxide particles (ferristene) as an endoluminal contrast agent: An open phase III trial

Magnetic Resonance Imaging

Volumn 22, Issue 8, 2004, Pages 1085-1095

  Boraschi, Piero ^a   Braccini, Giovanni ^a   Gigoni, Roberto ^a   Cartei, Federico ^a   Perri, Giuseppe ^a  

^a UNIVERSITY HOSPITAL OF PISA   (Italy)

Author keywords

Contrast media; Crohn's disease; Experimental study; Intestines; Magnetic resonance (MR); MRI

Indexed keywords

CONTRAST MEDIUM; ENEMA; FERRISTENE; GADOLINIUM PENTETATE; PROTON; SCOPOLAMINE BUTYL BROMIDE; SUPERPARAMAGNETIC IRON OXIDE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROHN DISEASE; DENSITY; DIAGNOSTIC ACCURACY; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEADACHE; HUMAN; MALE; MATHEMATICAL COMPUTING; NAUSEA; NUCLEAR MAGNETIC RESONANCE; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; SIDE EFFECT; STATISTICAL SIGNIFICANCE; VOMITING;

ADULT; AGED; ARTIFACTS; CONTRAST MEDIA; CROHN DISEASE; ENEMA; FEMALE; FERRIC COMPOUNDS; GADOLINIUM DTPA; HUMANS; INJECTIONS, INTRAVENOUS; INTESTINE, SMALL; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED;

EID: 7544251754     PISSN: 0730725X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mri.2004.01.077     Document Type: Article

References (30)

1. Keogan M.T., Edelman R.R. Technologic advances in abdominal MR imaging. Radiology. 220:2001;310-320
2. Luboldt W., Steiner P., Bauerfeind P., Pelkonen P., Debatin J.F. Detection of mass lesions with MR colonography preliminary report. Radiology. 207:1998;59-65
3. Luboldt W., Bauerfeind P., Wildermuth S., Marincek B., Fried M., Debatin J.F. Colonic masses detection with MR colonography. Radiology. 216:2000;383-388
4. Paley M.R., Ros P.R. MRI of the gastrointestinal tract. Eur Radiol. 7:1997;1387-1397
5. Ha H.K., Lee E.H., Lim C.H., et al. Application of MRI for small intestinal diseases. Magn Reson Imaging. 8:1998;375-383
6. Debatin J.F., Patak M.A. MRI of the small and large bowel. Eur Radiol. 9:1999;1523-1534
7. Barish M.A., Jara H. Motion artifact control in body MR imaging. Magn Reson Imaging Clin N Am. 7:1999;289-301
8. Brown J.J. Gastrointestinal contrast agents for MR imaging. Magn Reson Imaging Clin N Am. 4:1996;25-35
9. Aschoff A.J., Zeitler H., Merkle E.M., Reinshagen M., Brambs H.J., Rieber A. MR enteroclysis for nuclear spin tomographic diagnosis of inflammatory bowel diseases with contrast enhancement. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr. 167:1997;387-391
10. Rieber A., Wruk D., Nussle K., et al. MRI of the abdomen combined with enteroclysis in Crohn disease using oral and intravenous Gd-DTPA. Radiologe. 38:1998;23-28
11. Gourtsoyiannis N., Papanikolaou N., Grammatikakis J., Maris T., Prassopoulos P. MR imaging of the small bowel with a true-FISP sequence after enteroclysis with water solution. Invest Radiol. 35:2000;707-711
12. Rieber A., Aschoff A., Nussle K., et al. MRI in the diagnosis of small bowel disease use of positive and negative oral contrast media in combination with enteroclysis. Eur Radiol. 10:2000;1377-1382
13. Umschaden H.W., Szolar D., Gasser J., Umschaden M., Haselbach H. Small-bowel disease comparison of MR enteroclysis images with conventional enteroclysis and surgical findings. Radiology. 215:2000;717-725
14. Maglinte D.D., Siegelman E.S., Kelvin F.M. MR enteroclysis the future of small-bowel imaging? Radiology. 215:2000;639-641
15. Gourtsoyiannis N., Papanikolaou N., Grammatikakis J., Maris T., Prassopoulos P. MR enteroclysis protocol optimization comparison between 3D FLASH with fat saturation after intravenous gadolinium injection and true FISP sequences. Eur Radiol. 11:2001;908-913
16. Prassopoulos P., Papanikolaou N., Grammatikakis J., Rousomoustakaki M., Maris T., Gourtsoyiannis N. MR enteroclysis imaging of Crohn disease. Radiographics. 21:2001;S161-172
17. Matsumura M., Nakagami H., Chen C.J., Ito S., Konno T. Development of an abdominal magnetic resonance (MR) contrast agent formulation with Oral Magnetic Particles (OMP, Ferristene). Pharm Acta Helv. 73:1998;205-213
18. Laniado M., Gronewaller E., Kopp A.F., et al. The value of hyoscine butylbromide in abdominal MR imaging with and without oral magnetic particles. Abdom Imaging. 22:1997;381-388
19. Maglinte D.D., Kelvin F.M., O'Connor K., Lappas J.C., Chernish S.M. Current status of small bowel radiography. Abdom Imaging. 21:1996;247-257
20. Raptopoulos V., Schwartz R.K., McNicholas M.M., Movson J., Pearlman J., Joffe N. Multiplanar helical CT enterography in patients with Crohn's disease. AJR Am J Roentgenol. 169:1997;1545-1550
21. Reittner P., Goritschnig T., Petritsch W., et al. Multiplanar spiral CT enterography in patients with Crohn's disease uisng a negative oral contrast material initial results of a noninvasive imaging approach. Eur Radiol. 12:2002;2253-2257
22. Van Beers B.E., Grandin C., De Greef D., Lundby B., Pringot J. Ferristene as intestinal MR contrast agent. Distribution and safety of a fast ingestion procedure with oral metoclopramide. Acta Radiol. 37:1996;676-679
23. Jacobsen T.F., Laniado M., Van Beers B.E., et al. Oral magnetic particles (ferristene) as a contrast medium in abdominal magnetic resonance imaging. Acad Radiol. 3:1996;571-580
24. Lomas D.J., Graves M.J. Small bowel MRI using water as a contrast medium. Br J Radiol. 72:1999;994-997
25. Laghi A., Carbone I., Catalano C., et al. Polyethylene glicol solution as an oral contrast agent for MR imaging of the small bowel. AJR Am J Roentgenol. 177:2001;1333-1334
26. Faber S.C., Stehling M.K., Holzknecht N., Gauger J., Helmberger T., Reiser M. Pathologic conditions in the small bowel findings at fat-suppressed gadolinium-enhanced MR imaging with an optimized suspension of oral magnetic particles. Radiology. 205:1997;278-282
27. Nolzknecht N., Helmberger T., von Ritter C., Gauger J., Faber S., Reiser M. MRI of the small intestine with rapid MRI sequences in Crohn disease after enteroclysis with oral iron particles. Radiologe. 215:2000;717-725
28. Wallengren N.O., Holtas S., Andren-Sandberg A., Jonsson E., Kristoffersson D.T., McGill S. Rectal carcinoma double-contrast MR imaging for preoperative staging. Radiology. 215:2000;108-114
29. Maier A.G., Kersting-Sommerhoff B., Reeders J.W., et al. Staging of rectal cancer by double-contrast MR imaging using the rectally administered superparamagnetic iron oxide contrast agent ferristene and IV gadodiamide injection results of a multicenter phase II trial. J Magn Reson Imaging. 12:2000;651-660
30. Maglinte D.D., Kelvin F.M., Micon L.T., et al. Nasointestinal tube for decompression or enteroclysis experience with 150 patients. Abdom Imaging. 19:1994;108-112